Order results by:
| Issue | Title | |
| Vol 14, No 5 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... in 27 of 30 patients (90%) in DCC group and in 28 of 30 patients (93.3%) in PCV group. 95% confidence ..." | ||
| Vol 14, No 6 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety | Abstract PDF (Eng) similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... with persistent AF were randomized to groups of DCC (n=30) and pharmacologic conversion (PCV; n=30). There were ..." | ||
| Vol 7, No 2 (2011) | PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE | Abstract similar documents |
| I. V. Graifer, O. V. Reshet'ko, N. V. Furman | ||
| "... стабильной гемодинамикой проводили фармакологическую кардиоверсию. Наиболее часто для фармакологической ..." | ||
| Vol 12, No 5 (2016) | Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation | Abstract similar documents |
| N. A. Novikova, A. N. Volovchenko | ||
| "... кардиоэмболического инсульта. При выполнении электрической кардиоверсии данный риск значительно возрастает. Для ..." | ||
| Vol 6, No 6 (2010) | EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) | Abstract similar documents |
| T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov | ||
| "... Цель. Изучить эффективность и безопасность проведения кардиоверсии амиодароном и пропафеноном у ..." | ||
| Vol 12, No 3 (2016) | THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY | Abstract PDF (Eng) similar documents |
| T. Y. Gromyko, S. A. Sayganov | ||
| "... явились достоверными предикторами его сохранения сроком до 6 мес при любом способе кардиоверсии. ..." | ||
| Vol 9, No 4 (2013) | COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
| L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky | ||
| "... ) к проведению плановой кардиоверсии (КВ) при лечении варфарином и дабигатраном Материал и методы ..." | ||
| Vol 3, No 4 (2007) | PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY | Abstract similar documents |
| B. A. Tatarskii | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... ) после электрической кардиоверсии у больных ишемической болезнью сердца (ИБС) с пароксизмальной формой ФП ..." | ||
| Vol 10, No 4 (2014) | FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW | Abstract similar documents |
| S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva | ||
| "... методику выполнения электрической кардиоверсии. Приводят доказательную базу и анализ осложнений при ..." | ||
| Vol 10, No 3 (2014) | EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION | Abstract similar documents |
| "... кардиоверсии. ..." | ||
| Vol 17, No 2 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
| N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
| Vol 17, No 5 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety | Abstract similar documents |
| N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
| Vol 21, No 2 (2025) | Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion | Abstract similar documents |
| Kh. M. Dzaurova, N. Yu. Mironov, Yu. A. Yuricheva, M. M. Belyaeva, S. F. Sokolov, N. A. Mironova, S. P. Golitsyn, O. Yu. Korennova, I. M. Zueva, E. A. Turusheva, D. S. Terekhov | ||
| "... использования кавутилида указывает на целесообразность рассмотрения возможности медикаментозной кардиоверсии ..." | ||
| Vol 14, No 4 (2018) | Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment | Abstract similar documents |
| Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova | ||
| "... кардиоверсии и электроимпульсной терапии. Показана целесообразность вв введения бета-адреноблокаторов, а в ..." | ||
| Vol 19, No 2 (2023) | Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative? | Abstract similar documents |
| I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva | ||
| "... аблацией (КА) или кардиоверсией (КВ) у больных с неклапанной фибрилляцией (нФП) или трепетанием предсердий ..." | ||
| Vol 19, No 1 (2023) | Relief of persistent atypical atrial flutter: experience with the use of niferidil | Abstract similar documents |
| E. A. Zakharyan, D. V. Shatov, A. O. Povoroznyj, T. B. Bujar | ||
| "... начала терапии. Представленный клинический случай подтверждает эффективность медикаментозной кардиоверсии ..." | ||
| Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
| "... дабигатраном при развитии инсульта, при необходимости электрической или фармакологической кардиоверсии ..." | ||
| Vol 13, No 1 (2017) | COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY | Abstract similar documents |
| A. V. Tarasov, K. V. Davtyan, S. Yu. Martsevich | ||
| "... ,37 медикаментозных кардиоверсий против 13,24±10,77 в группе 1 (р=0,013) и против 11,93±12,02 в группе 3 (р=0,123). В ..." | ||
| Vol 14, No 3 (2018) | NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES | Abstract similar documents |
| G. S. Galjautdinov1, I. V. Gorelkin, K. R. Ibragimova, R. R. Sadriev | ||
| "... кардиогенным шоком, ФП требует экстренной кардиоверсии: медикаментозной или электроимпульсной. В ряде случаев ..." | ||
| Vol 21, No 3 (2025) | Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician? | Abstract similar documents |
| I. S. Yavelov | ||
| "... результатам исследования X-VERT при кардиоверсии ривароксабан представляется эффективной и безопасной ..." | ||
| Vol 13, No 6 (2017) | HEART RATE VARIABILITY, VENTRICULAR LATE POTENTIALS AND HEART RATE TURBULENCE AS INDICATORS OF CORONARY REPERFUSION IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| E. A. Shigotarova, E. V. Dushina, V. A. Galimskaya, V. E. Oleynikov | ||
| "... 40 мс комплекса QRS после ЧКВ (до 49±50,3 мкВ). Патологические отклонения показателей турбулентности ..." | ||
| Vol 17, No 3 (2021) | An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus | Abstract similar documents |
| V. N. Larina, O. Sh. Oynotkinova, A. P. Majorova, G. A. Egiazarian, T. Yu. Demidova | ||
| "... его частоты, выбора между аблацией, кардиоверсией и антиаритмическими препаратами, а также для ..." | ||
| Vol 13, No 5 (2017) | LEFT ATRIAL FUNCTION: MODERN ASSESSMENT METHODS AND CLINICAL SIGNIFICANCE | Abstract similar documents |
| E. N. Pavlyukova, D. A. Kuzhel, G. V. Matyushin | ||
| "... синусового ритма после кардиоверсии и катетерной абляции. Низкие значения глобальной деформации ЛП указывают ..." | ||
| 1 - 24 of 24 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
